Female Reproductive Health

CONRAD’s mission to improve reproductive health globally drives our development of new, innovative technologies. To date, we have been primarily focused on HIV/STI prevention and contraception. More recently, we have started to develop concepts in the area of prevention of maternal and neonatal morbidity. Preterm labor and premature deliveries, postpartum hemorrhage and perinatal infections are the leading causes of maternal and neonatal morbidity and mortality in the developing world. CONRAD is seeking expanded funding to design, develop, and manufacture product concepts to test in collaboration with the EVMS department of Obstetrics and Gynecology.



A14-131 – The Role of Vitamin D in Female Reproductive Tract Immunity

(Clinicaltrials.gov Identifier: NCT02186535)